Business
Press Release Nov 14 2022
Biocon Limited has informed the Exchange about press release dated 14-Nov-2022 titled "Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% ; Gross R&D Spend at Rs 252 Crore, Up 52%; Biosimilars Up 34%; Research Services Up 26%; Generics Up 18%."
About this update from Biocon Limited
[{"type":"text","content":" Biocon Limited has informed the Exchange about press release dated 14-Nov-2022 titled \"Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% ; Gross R&D Spend at Rs 252 Crore, Up 52%; Biosimilars Up 34%; Research Services Up 26%; Generics Up 18%.\" View Attachment","length":424,"tagName":"div"}]